Trudy Oliver Tracks a Deadly, Shapeshifting Tumor

Trudy Oliver Tracks a Deadly, Shapeshifting Tumor

Trudy Oliver, PhD, studies a type of cancer that has a 5-year overall survival rate of just 7%. Its biological drivers are different from most other cancers, so it's harder to develop targeted treatments. On top of that, research into this tumor is under-funded.